Transient Fluorescent Tattoos Mark Surgical Sites

The result is micrometer-sized c-FSNPs, which exhibit an ideal size-dependent intradermal retention time of up to three months.

The temporary pigment has optimized photophysical properties and intradermal retention time for successful in vivo finite tattooing. Under ambient lighting, the nanoparticles are invisible, avoiding unwanted markings on a patient's skin; but under a light at a wavelength of 465 nanometers, the pigment glows fluorescently, marking the surgical target. In addition, the inflammatory responses induced by c-FSNPs are undetectable after tattooing. The study describing the new pigment was published on November 30, 2016, in ACS Nano.

“Commercially available tattoo pigments possess several issues, which include causing poor cosmesis, being mistaken for a melanocytic lesion, requiring additional removal procedures when no longer desired, and potentially inducing inflammatory responses,” concluded senior author Hsian-Rong Tseng, PhD, of CNSI, and colleagues. “We believe that the c-FSNPs can serve as a ‘finite tattoo’ pigment to label potential malignant nonmelanoma skin cancer lesions.”

Tattooing has been utilized by the medical community for precisely demarcating anatomic landmarks, which is especially important for identifying biopsy sites of nonmelanoma skin cancer (NMSC) due to the long interval between the initial diagnostic biopsy and surgical treatment.

Related Links:
California NanoSystems Institute
Academia Sinica